anubhai
Back OfficeBajaj Finserv Healthcare Fund - Regular (IDCW)
Summary
| Fund Name | Bajaj Finserv Mutual Fund |
| Scheme Name | Bajaj Finserv Healthcare Fund - Regular (IDCW) |
| AMC | Bajaj Finserv Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 06-Dec-2024 |
| Fund Manager | Nimesh Chandan |
| Net Assets(Rs. cr) | 338.55 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | -0.40 | -2.34 | -3.12 | 3.05 | 0.00 | 0.00 | 0.00 | -3.15 |
| Category Avg | -0.65 | -1.89 | -3.28 | 2.86 | -1.68 | 22.86 | 15.85 | 13.88 |
| Category Best | 0.01 | -0.44 | -1.28 | 7.18 | 4.67 | 28.64 | 18.86 | 29.46 |
| Category Worst | -1.75 | -3.12 | -6.22 | -1.75 | -8.43 | 18.98 | 11.80 | -5.86 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Divi's Lab. | 8.41 |
| Sun Pharma.Inds. | 8.24 |
| Apollo Hospitals | 5.93 |
| Aurobindo Pharma | 5.54 |
| Cipla | 5.06 |
| Piramal Pharma | 4.40 |
| Neuland Labs. | 4.26 |
| Biocon | 4.00 |
| Emcure Pharma | 3.43 |
| Fortis Health. | 3.26 |
| Rubicon Research | 2.47 |
| Lupin | 2.23 |
| Ipca Labs. | 2.17 |
| Glenmark Pharma. | 2.05 |
| Pfizer | 1.96 |
| Shaily Engineer. | 1.91 |
| Sanofi Consumer | 1.91 |
| Vijaya Diagnost. | 1.82 |
| Zydus Wellness | 1.75 |
| Godrej Consumer | 1.69 |
| Dr Lal Pathlabs | 1.59 |
| Glaxosmi. Pharma | 1.59 |
| Abbott India | 1.54 |
| Medi Assist Ser. | 1.41 |
| Medplus Health | 1.23 |
| Max Healthcare | 1.20 |
| Rainbow Child. | 1.18 |
| Hind. Unilever | 1.14 |
| Torrent Pharma. | 1.13 |
| Jubilant Pharmo | 1.13 |
| Alembic Pharma | 1.07 |
| Syngene Intl. | 1.06 |
| Tata Consumer | 1.04 |
| Emami | 1.02 |
| Mankind Pharma | 0.97 |
| Astrazeneca Phar | 0.87 |
| Eternal Ltd | 0.78 |
| Marico | 0.67 |
| C C I | 4.34 |
| Net CA & Others | -1.08 |
| Bajaj Finserv Money Market Fund - Direct (G) | 1.49 |
| Aurobindo Pharma | 2.14 |
